CPHRF - Cipher Pharmaceuticals EPS beats by $0.02 beats on revenue November, 12 2020 10:10 PM Companhia Siderurgica Paulista Nova Cosipa Cipher Pharmaceuticals (CPHRF): Q3 GAAP EPS of $0.06 beats by $0.02.Revenue of $4.9M (-15.5% Y/Y) beats by $0.94M.Press Release For further details see: Cipher Pharmaceuticals EPS beats by $0.02, beats on revenue